These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31218127)

  • 1. PGM5: a novel diagnostic and prognostic biomarker for liver cancer.
    Jiao Y; Li Y; Jiang P; Han W; Liu Y
    PeerJ; 2019; 7():e7070. PubMed ID: 31218127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients.
    Sun Y; Long H; Sun L; Sun X; Pang L; Chen J; Yi Q; Liang T; Shen Y
    Cancer Cell Int; 2019; 19():253. PubMed ID: 31582909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
    Qian M; Zheng JL; Kang N; Su YL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
    Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer.
    Jiang Y; Li J; Sang C; Cao G; Wang S
    Ann Transl Med; 2020 Sep; 8(18):1164. PubMed ID: 33241013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer.
    Sun J; Wang F; Zhou H; Zhao C; Li K; Fan C; Wang J
    Discov Oncol; 2022 Jul; 13(1):63. PubMed ID: 35819729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis.
    Ran F; Zhang Y; Shi Y; Liu J; Li H; Ding L; Ye Q
    J Oncol; 2021; 2021():5529770. PubMed ID: 33986801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HN1 as a diagnostic and prognostic biomarker for liver cancer.
    Liu Z; Yang D; Li Y; Jiao Y; Lv G
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
    Yang D; Ji F; Li Y; Jiao Y; Fang X
    Technol Cancer Res Treat; 2020; 19():1533033820945817. PubMed ID: 32812493
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jiao Y; Li Y; Liu S; Chen Q; Liu Y
    Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
    Yue Q; Meng L; Jia B; Han W
    Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer.
    Jiao Y; Li Y; Jiang P; Fu Z; Liu Y
    Sci Rep; 2019 Dec; 9(1):19865. PubMed ID: 31882722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
    Lin M; Li Y; Qin S; Jiao Y; Hua F
    Oncol Lett; 2020 Apr; 19(4):2773-2784. PubMed ID: 32218830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
    Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
    IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the effect of PGM on survival prognosis of tumor patients.
    Zheng Z; Bai J; Shen S; Zhu C; Zhou Y; Zhang X
    Front Oncol; 2022; 12():1060372. PubMed ID: 36544711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer.
    Zhang Y; Chen Z; Jiang A; Gao G
    Sci Rep; 2022 Feb; 12(1):1976. PubMed ID: 35132098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
    Jiao Y; Li Y; Ji B; Cai H; Liu Y
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
    Wu W; Sui J; Liu T; Yang S; Xu S; Zhang M; Huang S; Yin L; Pu Y; Liang G
    PeerJ; 2019; 7():e6761. PubMed ID: 31065456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.